Picture of Shanghai Bio-heart Biological Technology logo

2185 — Shanghai Bio-heart Biological Technology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareMicro CapSucker Stock

Brief: Shanghai Bio-Heart Biological Technology Says Trial Of Sirolimus Be In Japan

Nov 18 (Reuters) - Shanghai Bio-heart Biological
Technology  2185.HK :
    * CLINICAL TRIAL OF SIROLIMUS DRUG-ELUTING BALLOON WILL BE
CONDUCTED IN JAPAN

Further company coverage:  2185.HK 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Shanghai Bio-heart Biological Technology

See all news